Since the common pathway in CKD relates to tubulointerstitial damage which in turn could imply high levels of monomer NGAL, a tool that allows the measurement of monomer NGAL only, would not be helpful in differentiating between AKI, acute on chronic kidney disease and CKD. This evidence concerns the gene LCN2 and acute kidney injury.